Alpha 1 Antitrypsin Gene Therapy Extends the Lifespan of Lupus-Prone Mice-Reference-Cited by-同舟云学术

Alpha 1 Antitrypsin Gene Therapy Extends the Lifespan of Lupus-Prone Mice

Published:2018-12 Issue: Volume:11 Page:131-142
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Elshikha Ahmed Samir,Yuan Ye,Lu Yuanqing,Chen Mong-Jen,Abboud Georges,Akbar Mohammad Ahsanul,Plate Henrike,Wolney Hedwig,Hoffmann Tanja,Tagari Eleni,Zeumer Leilani,Morel Laurence,Song Sihong

Funder

University of Florida

Grifols Inc.

Egypt Government Scholarship

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference63 articles.

1. Treatment of severe lupus nephritis: the new horizon;Chan;Nat. Rev. Nephrol.,2015

2. The role of dendritic cells in autoimmunity;Ganguly;Nat. Rev. Immunol.,2013

3. Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage;Teichmann;Immunity,2010

4. A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW/F1 mice;Zhu;Autoimmunity,2013

5. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors;Kawai;Nat. Immunol.,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meditation-induced bloodborne factors as an adjuvant treatment to COVID-19 disease;Brain, Behavior, & Immunity - Health;2023-10

2. Human Alpha-1 Antitrypsin Attenuates ENaC and MARCKS and Lowers Blood Pressure in Hypertensive Diabetic db/db Mice;Biomolecules;2022-12-29

3. Urinary serpin-A3 is an early predictor of clinical response to therapy in patients with proliferative lupus nephritis;American Journal of Physiology-Renal Physiology;2022-10-01

4. Alpha-1 antitrypsin in autoimmune diseases: Roles and therapeutic prospects;International Immunopharmacology;2022-09

5. A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application;International Journal of Molecular Sciences;2022-02-23